The link between excitotoxic oligodendroglial death and demyelinating diseases
Related Experiment Video
Updated: Oct 9, 2026

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
Published on: February 5, 2015
C Matute1, E Alberdi, M Domercq
1Departamento de Neurociencias, Universidad del País Vasco, 48940 Leioa, Spain. onpmaalc@lg.ehu.es
Abstract:
Oligodendrocytes, the myelinating cells of CNS axons, are highly vulnerable to excitotoxic signals mediated by glutamate receptors of the AMPA and kainate classes. Receptors in these cells are commonly activated by glutamate that is released from axons and glial cells. In addition, oligodendrocytes contribute to the control of extracellular glutamate levels by means of their own transporters. However, acute and chronic alterations in glutamate homeostasis can result in overactivation of AMPA and kainate receptors and subsequent excitotoxic oligodendroglial death. Furthermore, demyelinating lesions caused by excitotoxins can be similar to those observed in multiple sclerosis. This, together with the effect of AMPA and kainate receptor antagonists in ameliorating the neurological score of animals with experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis), indicates that oligodendrocyte excitotoxicity could be involved in the pathogenesis of demyelinating disorders.
Insights
Oligodendrocytes are vulnerable to excitotoxicity from glutamate receptor overactivation, leading to cell death and demyelination. This suggests excitotoxicity may play a role in demyelinating disorders like multiple sclerosis.
Area of Science:
- Neuroscience
- Cell Biology
- Pathology
Background:
- Oligodendrocytes, the myelinating cells of the central nervous system (CNS), are susceptible to excitotoxic damage.
- Glutamate receptors, specifically AMPA and kainate types, mediate this excitotoxicity.
- Glutamate is released from neurons and glial cells, and oligodendrocytes also regulate extracellular glutamate levels.
Purpose of the Study:
- To investigate the role of oligodendrocyte excitotoxicity in demyelinating disorders.
- To explore the link between glutamate homeostasis, receptor activation, and oligodendrocyte death.
- To assess the potential involvement of excitotoxicity in the pathogenesis of multiple sclerosis.
Main Methods:
- Analysis of oligodendrocyte vulnerability to excitotoxic signals.
- Investigation of glutamate receptor activation in oligodendrocytes.
- Examination of glutamate transporter function in oligodendrocytes.
- Comparison of excitotoxin-induced demyelination with lesions in multiple sclerosis models.
Main Results:
- Alterations in glutamate homeostasis can lead to overactivation of AMPA and kainate receptors.
- This overactivation results in excitotoxic death of oligodendrocytes.
- Excitotoxin-induced demyelinating lesions resemble those seen in multiple sclerosis.
- AMPA and kainate receptor antagonists improve neurological scores in experimental autoimmune encephalomyelitis models.
Conclusions:
- Oligodendrocyte excitotoxicity, driven by glutamate receptor overactivation, is a significant threat to CNS myelin.
- The findings suggest that oligodendrocyte excitotoxicity may be a key factor in the development of demyelinating diseases.
- Targeting AMPA and kainate receptors could be a therapeutic strategy for demyelinating disorders such as multiple sclerosis.
Related Concept Videos
Secondary Spinal Cord Injury llI: Pathophysiology
Cytotoxic Edema: Pathophysiology
Cellular Injury IV: Necrosis
